FBL and hepatocellular carcinoma: According to the immunohistochemistry results, we divided hepatocellular carcinoma patients into a low FBL expression group (Figure 7C, Negative and Weak) and a high FBL expression group (Figure 7C, Moderate and Strong), and the clinical data were sorted and analyzed according to the grouping (Table 1).